Delivery Order SPE2DB20D2104-SPE2DB23FV39D
- Not listed
- This federal contract award, valued at $8,091.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Janumet 50-1,000 mg tablets, a medication used to manage diabetes. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, which is valued at up to $999,999,999.00 and runs through November 2026. This larger IDC serves as the...
- This federal contract award, valued at $1,325.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet 50-1,000 mg Tablets, a medication used to treat type 2 diabetes. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $17,090.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the provision of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 7, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established...
- This federal contract award, valued at $10,709.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The award is a Firm Fixed Price Delivery Order with a completion date of May 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,524.70 delivery order contract is for the procurement of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a period of performance through May 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award, valued at $13,001.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. This is a firm fixed-price delivery order contract with a completion date of December 29, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for...
- This federal contract award, valued at $1,848.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is a delivery order, with a firm fixed price and an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,916.54 delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has a firm fixed price and an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds...
- This federal contract award is a delivery order valued at $4,581.31 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award, valued at $9,216.43, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV39DDelivery Order
This federal contract award, valued at $11,854.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 19, 2023. The contract award does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract allows the DLA to efficiently procure essential healthcare commodities for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/18/23 |